Amplifon seeks share issue of 56,000,000 shares to GN Store Nord for GN Hearing deal
Bitget2026/09/29 05:15- Amplifon shareholders meet Oct. 29, 2026 to vote a reserved capital increase tied to the planned GN Hearing acquisition.
- Proposal calls for 56,000,000 new ordinary shares at EUR 11.2670 each, raising EUR 630.95 million with pre-emption rights excluded.
- Shares would be subscribed solely by GN Store Nord via set-off against the purchase price; maximum dilution for existing holders estimated at 17.09%.
- Extraordinary agenda also includes articles-of-association changes reflecting Italy’s Legislative Decree 47/2026, including updated shareholder-meeting participation rules.
- Board-backed resolutions also include confirming Francesca Fiore as director following co-option, plus adding one director post-closing to accommodate GN’s nominee.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Charles Schwab survey finds 60% of US crypto investors plan increased holdings in 2026
IEFA ETF Declines 1.1%
This article was automatically generated using Dow Jones technology. Shares of iShares Core MSCI EAFE ETF shed 1.1% to $96.20 Wednesday on what proved to be an overall poor trading session for the U.S. stock market, with the S&P 500 Index falling 0.2% to 7,801.77. The fund's fall snapped a three-day winning streak. The ETF's shares closed 5.2% below the 52-week high of $101.44 seen on August 28, 2026. Trading volume was 11,673,074, compared to the 65-day average trading volume of 8,811,386. As of October 6, the fund's net asset value totaled $97.24 per share. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 07, 2026 16:35 ET (20:35 GMT)
Moderna Inc. Stock Rises 4.8%, Outperforms Peers
This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Moderna Inc. advanced 4.8% to $196.48 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.2% to 27,538.69 and Dow Jones Industrial Average falling 0.7% to 51,179.87. Moderna Inc. closed 7.4% short of its 52-week high of $212.22, which the company achieved on October 6th. The stock outperformed some of its peers, as Johnson & Johnson rose 1.4% to $258.45, Pfizer Inc. rose 1.8% to $28.00, and Gilead Sciences Inc. rose 1.82% to $146.85. Trading volume totaled 14.6 million, compared to the 50-day average of 20.7 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 07, 2026 16:33 ET (20:33 GMT)
BUZZ-Wolfspeed receives conditional loan commitment of up to 1.5 billions USD from the US
October 7 — Wolfspeed (WOLF.N), a chip company, saw its stock price rise by 27.4% in after-hours trading to $39.89. Wolfspeed announced it has received a conditional loan commitment of up to $1.5 billion over 30 years from the U.S. Department of Defense to expand domestic production of silicon carbide materials and power devices. “We believe the size of this conditional commitment and its 30-year duration reflect the long-term importance of Wolfspeed’s technical and manufacturing capabilities established in the U.S.,” said CEO Robert Feurle. As of the last trading day’s close, the company’s stock has risen about 80% year-to-date. (For the convenience of non-English speakers, Reuters has automated the translation of its report into several languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of these texts and provides them solely for readers’ convenience. Reuters bears no responsibility for any damages or losses caused by the use of automated translations.)
Crypto prices
More
